SUNOSI
Active substance: solriamfetol
TABLET, FILM COATED · SOLRIAMFETOL 150 mg/1
United StatesActive
Marketing holder: Axsome Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SOLRIAMFETOL · 150 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a12091-106a-7abe-96cd-c527cf98c7b9,01a1209a-2594-7cc7-96bb-1d0717eb5501;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 81968-351
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 81968-351 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 81968-351 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 81968-351 · Verified 2026-10-09 · open in source